Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Guangzhou Baiyunshan Pharmaceutical Holdings Co's quarterly Beginning Cash Position
increased
from Dec. 2025 (¥11,920 Mil) to Mar. 2026 (¥12,556 Mil) but then
declined
from Mar. 2026 (¥12,556 Mil) to Jun. 2026 (¥9,954 Mil).
Guangzhou Baiyunshan Pharmaceutical Holdings Co's annual Beginning Cash Position
declined
from Dec. 2023 (¥20,805 Mil) to Dec. 2024 (¥19,824 Mil) and
declined
from Dec. 2024 (¥19,824 Mil) to Dec. 2025 (¥16,303 Mil).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Beginning Cash Position Chart
Guangzhou Baiyunshan Pharmaceutical Holdings Co Annual Data
What does a Beginning Cash Position of ¥9,954 Mil mean?
Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332) has a Beginning Cash Position of ¥9,954 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Guangzhou Baiyunshan Pharmaceutical Holdings Co and its competitors.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co's Beginning Cash Position too high?
Guangzhou Baiyunshan Pharmaceutical Holdings Co's current Beginning Cash Position is ¥9,954 Mil. Overall, Guangzhou Baiyunshan Pharmaceutical Holdings Co has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Baiyunshan Pharmaceutical Holdings Co's Beginning Cash Position compare to MCK and COR?
Guangzhou Baiyunshan Pharmaceutical Holdings Co's Beginning Cash Position of ¥9,954 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Distribution company?
A good Beginning Cash Position depends on the Medical Distribution industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Guangzhou Baiyunshan Pharmaceutical Holdings Co and its competitors. Guangzhou Baiyunshan Pharmaceutical Holdings Co's current Beginning Cash Position is ¥9,954 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥28.27, compared to a current price of ¥20.22 — trading 28.5% below its estimated fair value. The current Beginning Cash Position is ¥9,954 Mil. Guangzhou Baiyunshan Pharmaceutical Holdings Co's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332), the current Beginning Cash Position is ¥9,954 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332) Overvalued in 2026?
Based on GuruFocus' analysis, Guangzhou Baiyunshan Pharmaceutical Holdings Co stock appears to be undervalued.
The current stock price of ¥20.22 is trading 28.5% below its estimated GF Value™ of ¥28.27.
GuruFocus considers Guangzhou Baiyunshan Pharmaceutical Holdings Co to be Modestly Undervalued.
Key valuation signals for SHSE:600332:
Beginning Cash Position: ¥9,954 Mil
GF Value™: ¥28.27 vs. price of ¥20.22 (28.5% below fair value)
No single metric tells the full story. See the SHSE:600332 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is engaged in the pharmaceutical and healthcare industry, focusing on the development of a full industrial chain covering research, manufacturing, and distribution. The group operates through five reportable segments. The Modern Chinese Medicine segment involves the R&D, manufacturing, and sale of proprietary Chinese and natural medicines. The Chemical Pharmaceutical Technology segment focuses on chemical drugs, APIs, and intermediates. The Natural Beverages segment produces and sells health-oriented beverage products. The Pharmaceutical Commerce segment is engaged in the wholesale, retail, and import/export of medicines and medical devices. The Other Segments include biotechnology innovation, consumer health, and medical services.
72GF Score
Get the complete analysis for SHSE:600332
Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600332 has been successfully added to your 
